Summary & Overview

CPT 0225U: ePlex Respiratory Pathogen Panel 2, Multiplex RT–PCR

CPT code 0225U designates the ePlex® Respiratory Pathogen Panel 2 from GenMark Diagnostics, a proprietary multiplex RT–PCR assay with electrochemical detection for common viral and bacterial respiratory pathogens, including SARS–CoV–2. As a PLA code, 0225U applies to a single manufacturer-specific test and signals unique billing and coverage considerations for laboratories and payers nationwide.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents clinically, typical sites of service, and the scope of laboratory testing covered by this panel. The publication also summarizes payer coverage patterns, coding and billing benchmarks, and relevant policy updates affecting proprietary laboratory tests.

This analysis provides clinicians, laboratory managers, and billing professionals with context on clinical use of the panel, national reimbursement and coverage considerations, and operational implications for performing and reporting a manufacturer-specific respiratory pathogen assay. Data not available in the input will be identified as such in relevant sections.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare0225UCPTProprietary Laboratory AnalysesRespiratory Pathogen PanelMultiplex RT-PCRMolecular DiagnosticsLaboratory BillingSARS-CoV-2

Billing Code Overview

CPT code 0225U is a Proprietary Laboratory Analyses (PLA) code for the ePlex® Respiratory Pathogen Panel 2, GenMark Dx, manufactured by GenMark Diagnostics. The test is a multiplex reverse transcription–polymerase chain reaction (RT–PCR) assay with electrochemical detection that identifies common viral and bacterial respiratory pathogens, including SARS–CoV–2.

Service type: Clinical diagnostic laboratory testing — multiplex molecular respiratory pathogen panel
Typical site of service: Hospital laboratories, independent clinical diagnostic laboratories, and other certified laboratory settings where molecular respiratory testing is performed

Clinical & Coding Specifications

Clinical Context

A patient presents to an urgent care clinic in late fall with acute onset of fever, cough, nasal congestion, sore throat, and myalgias. The clinician evaluates the patient and documents upper respiratory signs with possible lower respiratory involvement and potential exposure to SARS–CoV–2. A respiratory specimen (nasopharyngeal swab or nasal swab) is collected and sent to the on-site or reference laboratory for multiplex molecular testing.

The laboratory performs the ePlex® Respiratory Pathogen Panel 2, GenMark Dx, reported with CPT code 0225U. This is a proprietary multiplex RT–PCR assay with electrochemical detection that identifies common viral and selected bacterial respiratory pathogens, including SARS–CoV–2. Results are typically reported within a single test run and returned to the ordering clinician to guide infection control, antiviral therapy decisions, antibiotic stewardship, and disposition (home versus inpatient). Typical sites of service include hospital laboratories, outpatient clinics with on-site lab services, urgent care centers, and reference laboratories.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier - standard reporting	Use for routine reporting when no special circumstances apply.

Taxonomy Code	Specialty	Notes
207Q00000X	Pathology & Laboratory Medicine	Physicians overseeing laboratory testing and result interpretation.
208D00000X	Diagnostic Radiology (Laboratory oversight roles)	Laboratories sometimes supervised by diagnostic specialists in hospital settings.
363A00000X	Laboratory Director	Clinical laboratory directors and clinical pathologists responsible for high-complexity testing.
207L00000X	Infectious Disease	Clinicians ordering multiplex respiratory pathogen testing for diagnostic management.
251B00000X	General Practice / Family Medicine	Common ordering providers in urgent care and outpatient settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J12.9`	Viral pneumonia, unspecified	Multiplex respiratory panel evaluates viral etiologies in patients with pneumonia.
`J06.9`	Acute upper respiratory infection, unspecified	Common indication for multiplex testing in patients with acute URI symptoms.
`J22`	Unspecified acute lower respiratory infection	Used when LRTI is suspected and broad pathogen detection is helpful.
`U07.1`	COVID-19	SARS–CoV–2 target included in the panel; relevant when COVID-19 is suspected.
`J10.1`	Influenza with other respiratory manifestations, seasonal influenza virus identified	Influenza detection is covered by multiplex panels or reflex testing.
`R05`	Cough	Symptom code frequently accompanying orders for respiratory pathogen testing.
`R50.9`	Fever, unspecified	Non-specific symptom prompting diagnostic pathogen testing.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87471`	Infectious agent detection by nucleic acid (DNA or RNA); Influenza A, direct probe technique	Often ordered alongside multiplex panels when focused influenza testing is required or for confirmation.
`87635`	Infectious agent detection by nucleic acid (DNA or RNA); SARS–CoV–2 (COVID-19), amplified probe technique	Commonly ordered or used in parallel when dedicated SARS–CoV–2 testing is needed outside the multiplex panel.
`87804`	Infectious agent antigen detection by immunoassay, multiple respiratory viruses	May be performed as a rapid point-of-care test in triage before or after multiplex molecular testing.
`87420`	Infectious agent detection by nucleic acid (DNA or RNA); Adenovirus, amplified probe technique	Specific pathogen testing that may be ordered if the multiplex panel is not available or to confirm specific targets.
`99000`	Handling and/or conveyance of specimen (specimen handling)	Ancillary service code used by some facilities for specimen pick-up/transport associated with laboratory testing.